0001209191-19-021050.txt : 20190322 0001209191-19-021050.hdr.sgml : 20190322 20190322172243 ACCESSION NUMBER: 0001209191-19-021050 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190322 FILED AS OF DATE: 20190322 DATE AS OF CHANGE: 20190322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cearnal Martin E CENTRAL INDEX KEY: 0001408500 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 19700742 MAIL ADDRESS: STREET 1: 31 UPPER MOUNTAIN AVENUE STREET 2: APARTMENT 2 CITY: MONTCLAIR STATE: NJ ZIP: 07042 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-22 0 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001408500 Cearnal Martin E 2525 WEST END AVE. SUITE 950 NASHVILLE TN 37203 1 1 0 0 Sr VP/Chief Commercial Officer Common Stock 2019-03-22 4 A 0 5000 5.98 A 149667 D Common Stock 2019-03-22 4 F 0 1250 5.62 D 148417 D Restricted stock award will vest 100% on March 18, 2023. This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares. Martin E. Cearnal by /s/ Michael Bonner as attorney-in-fact 2019-03-22